发明名称 |
METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE |
摘要 |
The disclosure provides methods of preventing, ameliorating or treating disruption of mitochondrial function and symptoms thereof. The methods provide administering aromatic-cationic peptides in effective amounts to prevent, treat or ameliorate the disruption of mitochondrial oxidative phosphorylation in a cell such as that found in a subject suffering from, or predisposed to a mitochondrial disease or disorder. In some embodiments, the methods comprise administering to a subject suffering from, or at risk for a mitochondrial disease or disorder, an effective amount of an aromatic-cationic peptide to subjects in need thereof. |
申请公布号 |
US2016002293(A1) |
申请公布日期 |
2016.01.07 |
申请号 |
US201414771411 |
申请日期 |
2014.02.28 |
申请人 |
STEALTH BIOTHERAPEUTICS CORP. |
发明人 |
Wilson D. Travis |
分类号 |
C07K5/11 |
主分类号 |
C07K5/11 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating a mammalian cell with a disruption of mitochondrial oxidative phosphorylation, wherein the disruption of mitochondrial oxidative phosphorylation is associated with at least one gene mutation, the method comprising: contacting the cell with a therapeutically effective amount of the peptide D-Arg-2′,6′-Dmt-Lys-Phe-NH2 or a pharmaceutically acceptable salt thereof, thereby treating or ameliorating the disruption of oxidative phosphorylation in the cell. |
地址 |
Monoco MC |